Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Gross Profit: 2022-2025

Historic Gross Profit for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to -$2.9 million.

  • Centessa Pharmaceuticals' Gross Profit fell 13.02% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 166.27%. This contributed to the annual value of -$10.1 million for FY2024, which is 247.23% down from last year.
  • Centessa Pharmaceuticals' Gross Profit amounted to -$2.9 million in Q3 2025, which was down 0.21% from -$2.9 million recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Gross Profit peaked at $15.0 million during Q1 2025, and registered a low of -$2.9 million during Q3 2025.
  • Its 3-year average for Gross Profit is -$979,091, with a median of -$2.5 million in 2024.
  • Per our database at Business Quant, Centessa Pharmaceuticals' Gross Profit slumped by 56.33% in 2023 and then surged by 693.12% in 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' Gross Profit (Quarterly) stood at -$2.2 million in 2022, then fell by 16.66% to -$2.6 million in 2023, then climbed by 3.54% to -$2.5 million in 2024, then decreased by 13.02% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q3 2025, -$2.9 million for Q2 2025, and $15.0 million during Q1 2025.